At a Glance
| 1cP-AL-LAD | 1cP-MiPLA | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 100–225 µg | 150–200 µg |
| Total Duration | 3.3–7 hrs | 2.1–4.2 hrs |
| Routes | oral | oral |
| Effects | 72 documented | 70 documented |
1cP-AL-LAD, a Psychedelic, and 1cP-MiPLA, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 67 documented effects in common, with 5 effects unique to 1cP-AL-LAD and 3 unique to 1cP-MiPLA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 1cP-AL-LAD | 1cP-MiPLA | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 100–225 µg | 150–200 µg |
| Total Duration | 3.3–7 hrs | 2.1–4.2 hrs |
| Routes | oral | oral |
| Effects | 72 documented | 70 documented |
| Level | 1cP-AL-LAD | 1cP-MiPLA |
|---|---|---|
| Threshold | 20 µg | 50 µg |
| Light | 50–100 µg | 100–150 µg |
| Common | 100–225 µg | 150–200 µg |
| Strong | 225–350 µg | 200–250 µg |
| Heavy | 350 µg | 300 µg |
1cP-AL-LAD
1cP-MiPLA
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.